Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / April / Beyond IOP
Health Economics and Policy Glaucoma News

Beyond IOP

Systematic review examines how lifestyle modifications could be used as complementary IOP-lowering strategies for glaucoma patients

4/24/2026 2 min read

Share


Glaucoma remains one of the leading causes of irreversible blindness worldwide, with global prevalence projected to exceed 110 million by 2040. Despite advances in diagnostics and therapeutics, intraocular pressure (IOP) reduction remains the only proven strategy to slow disease progression. However, a growing body of evidence suggests that lifestyle modifications may play a meaningful adjunctive role in glaucoma care – targeting both IOP-dependent and independent mechanisms.

A recent systematic review highlights the potential for interventions spanning diet, exercise, stress management, and sleep to influence glaucoma outcomes. While none of these approaches replace conventional therapies, they may offer additive benefits that are clinically relevant.

Credit: AdobeStock.com

Exercise and ocular perfusion

Among lifestyle factors, physical activity demonstrates some of the most consistent evidence. Moderate aerobic exercise – such as walking, cycling, or swimming – can reduce IOP acutely by up to 3–5 mmHg, with sustained reductions of around 1–3 mmHg reported over longer periods. Mechanistically, exercise appears to enhance ocular perfusion, improve endothelial function, and upregulate neurotrophic factors such as brain-derived neurotrophic factor (BDNF), supporting retinal ganglion cell survival. Importantly, clinicians should exercise caution with certain isometric or Valsalva-inducing activities, which may transiently elevate IOP, particularly in hypertensive patients.

Diet, nutrition, and neuroprotection

Nutritional factors also appear to influence both glaucoma risk and progression. Diets rich in leafy green vegetables, nitrates, and antioxidants (vitamins A, C, and E) have been associated with reduced incidence of primary open-angle glaucoma and slower visual field loss. These effects are thought to arise from improved vascular function and reduced oxidative stress – key contributors to optic nerve damage. Emerging evidence also supports a role for specific supplements, including flavonoids and nitric oxide precursors, which may modestly reduce IOP and enhance trabecular outflow.

Mind-body interventions and stress pathways

Psychological stress is increasingly recognized as a modifiable risk factor in glaucoma. Stress-related biochemical changes – such as elevated cortisol levels and systemic inflammation – may contribute to IOP fluctuations and optic nerve vulnerability. As such, mindfulness-based interventions, including meditation and controlled breathing techniques, have been shown to reduce IOP while also improving quality of life and reducing anxiety. These approaches may exert their effects through modulation of the hypothalamic–pituitary–adrenal axis and inflammatory pathways.

Sleep, smoking, and systemic health

Sleep quality and systemic health behaviors further intersect with glaucoma pathophysiology. Treatment of sleep apnea has been linked to slower visual field progression, likely through improved nocturnal oxygenation. Similarly, smoking cessation is also associated with reduced rates of retinal nerve fiber layer thinning, underscoring the already well-documented vascular and oxidative burden of tobacco use.

Integrating lifestyle into clinical care

Taken together, these findings from the systematic review support a more holistic approach to glaucoma management. Even modest, sustained reductions in IOP can translate into meaningful reductions in progression risk. Equally important are the non-IOP benefits, including improved ocular perfusion, reduced oxidative stress, and enhanced patient well-being.

For ophthalmologists, the practical implication is clear: lifestyle counselling should be considered part of routine glaucoma care. Encouraging patients to adopt a plant-rich diet, engage in regular aerobic exercise, manage stress through mindfulness techniques, optimize their sleep, and avoid smoking may not only complement medical and surgical treatments, but also empower patients in the long-term management of their disease.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: